Keywords: questions, raised, over, genentech, marketing, most, agree

Questions Raised Over Genentech's Marketing

Article | 23 January 1995

Print This

Most would agree that US bio-technology company Genentech has a rich pipeline of drugs for future launch, and this will ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in